Travis Sherer
,


Phill Wilson
,


Jim Sullivan on Improving the Lives of Patients

At AbbVie, research and innovation are the cornerstones of our business as a global biopharmaceutical company. We focus on developing medicines that deliver strong clinical performance, provide more patient benefit and deliver economic value, particularly where there is significant need around the world in certain disease areas. 

Select a Contributor Response

Conversations:

What are you excited about in the fight against HIV/AIDS?

View All Conversations

 

What are you excited about in the fight against HIV/AIDS?

Test Name
Test Title, Test Company

Read biography×
This is a test modal

Kathie Hiers: What are you excited about in the fight against HIV/AIDS?

Submitted by Emily on

We have made amazing advances in the field of HIV in the last 33 years.  Everyone knows how much better the medications are.  Antiretroviral therapy (ART) today has fewer side effects, reduced pill burdens, and better efficacy.  And then our world was turned upside down by the incredible discovery of HIV Prevention Trials Network 052!  We now know that persons living with HIV who are successful on and adherent to ART and who reach an undetectable viral load essentially cannot transmit the disease to others.  As a result, providers are scrambling to make sure that folks know their status, th

Kathie Hiers
,


Bill Arnold: What are you excited about in the fight against HIV/AIDS?

In this week’s Conversations Blog, I’m outlining some of the points that I find most salient in our continuing fight against HIV/AIDS in the United States.

Bill Arnold
,


Lawrence Stallworth: What are you excited about in the fight against HIV/AIDS?

When I was 17 years old, I found out I was HIV-positive. As a young, Black gay man, I remember the fear of rejection, and the incredible love and support I found among my family and friends. Since the day I first learned my HIV status, I have made it my personal responsibility to fight this disease until we achieve an AIDS-free generation. I know many young people out there feel the same because our risk of infection is high and access to treatment and care can be tenuous.

Lawrence Stallworth
,


Pages

Subscribe to PhRMA RSS